by Madaline Spencer | Aug 28, 2024
Bruce Cree, MD, PhD, Professor of Clinical Neurology at the University of California San Francisco, discusses a post hoc analysis of patient pain and quality of life data in treatment with Uplizna (inebilizumab-cdon) for neuromyelitis optica. ...
by Madaline Spencer | Aug 27, 2024
Anita Longoria, a patient advocate, discusses her journey to a myasthenia gravis (MG) diagnosis. Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal muscles. Common symptoms include weakness of...
by Madaline Spencer | Aug 26, 2024
Prem Subramanian, MD, PhD, Professor of Ophthalmology at the University of Colorado School of Medicine, discusses long-term data testing teprotumumab in patients with thyroid eye disease (TED). TED is a rare autoimmune disease that can dramatically...
by Madaline Spencer | Aug 23, 2024
Richard Wasserman, MD, PhD, Medical Director of Pediatric Allergy and Immunology at Medical City Children’s Hospital, discusses the FDA expanded label approval for Xembify (immune globulin subcutaneous human-klhw) for primary immunodeficiencies (PIDs). ...
by Madaline Spencer | Aug 22, 2024
Ponni Subbiah, MD, Senior Vice President of Acadia, Global Head of Medical Affairs and Chief Medical Officer, discusses long-term data from clinical trial extension of trofinetide in patients with Rett syndrome. Rett syndrome is a neurodevelopmental...
